# Ascendis Pharma A/S (ASND)

> Healthcare · DK · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ASND/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 595.56M | € 850.09M | € 267.42M | € 449.89M | € 1.44B |
| 2025 | € 729.55M | € -231.44M | € 43.48M | € 871.41M | € -162.75M |
| 2024 | € 376.74M | € -391.70M | € -318.67M | € 856.62M | € -105.71M |
| 2023 | € 283.04M | € -510.90M | € -498.55M | € 743.06M | € -145.70M |
| 2022 | € 55.88M | € -636.84M | € -557.13M | € 508.38M | € 263.35M |
| 2021 | € 9.27M | € -457.40M | € -526.93M | € 209.92M | € 883.64M |
| 2020 | € 8.70M | € -524.42M | € -366.88M | € 91.98M | € 838.71M |
| 2019 | € 16.69M | € -272.13M | € -226.04M | € 36.62M | € 597.11M |
| 2018 | € 13.38M | € -164.56M | € -178.92M | € 0 | € 280.05M |
| 2017 | € 1.96M | € -159.10M | € -123.33M | € 0 | € 187.21M |
| 2016 | € 5.99M | € -89.15M | € -79.19M | € 0 | € 176.61M |
| 2015 | € 10.68M | € -43.31M | € -58.55M | € 0 | € 120.33M |
| 2014 | € 18.44M | € -12.74M | € -24.81M | € 0 | € 45.81M |
| 2013 | € 26.87M | € 5.37M | € 6.73M | € 0 | € 6.30M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.31 |
| Liabilities / Eq | 0.59 |
| Current Ratio | 2.99 |

## Other views

- [Metrics](https://sponda.capital/en/ASND.md)
- [Charts](https://sponda.capital/en/ASND/charts.md)
- [Compare](https://sponda.capital/en/ASND/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.